España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Reviva Pharmaceuticals
RVPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.93
-0.01
-0.52%
Pre-Market: 7:59 PM EDT
Get Report
Comment
Reviva Pharmaceuticals (RVPH) Forecast
News
Earnings
Reviva Pharmaceuticals (RVPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Reviva Pharmaceuticals (NASDAQ:RVPH) Stock
Reviva Pharmaceuticals Stock (NASDAQ: RVPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 22, 2025
HC Wainwright & Co. Maintains Buy on Reviva P...
Benzinga Newsdesk
Tuesday, January 21, 2025
Reviva Pharmaceuticals Unusual Options Activity
Benzinga Insights
D. Boral Capital Maintains Buy on Reviva Phar...
Benzinga Newsdesk
Friday, January 10, 2025
Maxim Group Upgrades Reviva Pharmaceuticals t...
Benzinga Newsdesk
Roth MKM Initiates Coverage On Reviva Pharmac...
Benzinga Newsdesk
Wednesday, January 08, 2025
Reviva Pharmaceuticals Option Alert: 1,491 Ju...
Benzinga Newsdesk
Tuesday, December 17, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Reviva Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Reported Earlier, Reviva Pharmaceuticals Pric...
Benzinga Newsdesk
Monday, December 16, 2024
Reviva Proposes To Offer And Sell Shares Of ...
Benzinga Newsdesk
Reviva Announces Preliminary Topline Data For...
Benzinga Newsdesk
Thursday, November 14, 2024
Reviva Pharmaceuticals Q3 2024 GAAP EPS $(0.2...
Benzinga Newsdesk
D. Boral Capital Maintains Buy on Reviva Phar...
Benzinga Newsdesk
Wednesday, November 13, 2024
D. Boral Capital Maintains Buy on Reviva Phar...
Benzinga Newsdesk
Tuesday, November 12, 2024
Reviva Pharmaceuticals Holdings shares are tr...
Benzinga Newsdesk
Reviva Announces Enrollment Update For Open L...
Benzinga Newsdesk
Wednesday, November 06, 2024
Reviva To Present Speech Latency Data For Bri...
Benzinga Newsdesk
Thursday, October 24, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, October 07, 2024
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Vandana Singh
Monday, September 23, 2024
EF Hutton Initiates Coverage On Reviva Pharma...
Benzinga Newsdesk
Monday, September 09, 2024
Reviva Pharmaceuticals Presents New Vocal Bio...
Benzinga Newsdesk
Tuesday, August 27, 2024
Reviva To Host Virtual KOL Event To Discuss V...
Benzinga Newsdesk
Monday, August 26, 2024
Benchmark Reiterates Speculative Buy on Reviv...
Benzinga Newsdesk
Wednesday, August 21, 2024
Reviva Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Reviva Pharmaceuticals Priced An Underwritten...
Benzinga Newsdesk
Friday, August 16, 2024
Reviva Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Maxim Group Downgrades Reviva Pharmaceuticals...
Benzinga Newsdesk
Wednesday, August 14, 2024
Reviva Pharmaceuticals Q2 2024 GAAP EPS $(0.2...
Benzinga Newsdesk
Tuesday, August 06, 2024
Reviva Announces Grant Of U.S. Patent 1205347...
Benzinga Newsdesk
Thursday, July 11, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, July 09, 2024
Reviva Granted A European Patent Covering The...
Benzinga Newsdesk
Thursday, June 20, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, June 11, 2024
HC Wainwright & Co. Maintains Buy on Reviva P...
Benzinga Newsdesk
Tuesday, May 28, 2024
Benchmark Reiterates Speculative Buy on Reviv...
Benzinga Newsdesk
Reviva Announces $3M Registered Direct Offeri...
Benzinga Newsdesk
Wednesday, May 15, 2024
Reviva Provides Enrollment Update For Its Ope...
Benzinga Newsdesk
Tuesday, May 14, 2024
Reviva Pharmaceuticals Q1 EPS $(0.25) Beats $...
Benzinga Newsdesk
Monday, May 13, 2024
Reviva To Present New Preclinical Efficacy Da...
Benzinga Newsdesk
Thursday, May 09, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Monday, April 22, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, April 16, 2024
Benchmark Reiterates Speculative Buy on Reviv...
Benzinga Newsdesk
Monday, April 15, 2024
Reviva Pharmaceuticals Q4 EPS $(0.35) Misses ...
Benzinga Newsdesk
Reviva Announces Alignment With FDA On Brilar...
Benzinga Newsdesk
Thursday, March 28, 2024
Reviva To Present RECOVER Phase 3 Clinical Tr...
Benzinga Newsdesk
Tuesday, March 26, 2024
Reviva Pharmaceuticals Holdings shares are tr...
Benzinga Newsdesk
Reviva to Present RECOVER Phase 3 Clinical Tr...
Benzinga Newsdesk
Monday, March 25, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, February 20, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, February 06, 2024
Reviva to Host KOL Event To Discuss Topline D...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
